XML 15 R48.htm IDEA: XBRL DOCUMENT v3.2.0.727
Related Party Transactions (Details Textual)
 1 Months Ended 6 Months Ended 12 Months Ended
May. 20, 2014
USD ($)
Dec. 06, 2011
USD ($)
$ / shares
May. 31, 2015
USD ($)
Nov. 30, 2014
May. 19, 2014
USD ($)
Installments
Oct. 24, 2013
Apr. 30, 2012
shares
Jun. 30, 2014
USD ($)
shares
Jun. 30, 2015
USD ($)
$ / shares
shares
Dec. 31, 2013
USD ($)
shares
Class of Warrant or Right [Line Items]                    
Term of warrants       5 years            
Proceeds from sale of Series A preferred stock                    
Issuance of common stock to founder for cash $ 2,000,000                  
Issuance of common stock to acquire Medeor, Inc. at fair value, Shares | shares             683      
Research and development expense                   $ 3,750,000
Common Stock                    
Class of Warrant or Right [Line Items]                    
Issuance of common stock for services, Shares | shares               5,810 83,333 11,279
Issuance of common stock to acquire Medeor, Inc. at fair value, Shares | shares                   100,000
Medeor [Member]                    
Class of Warrant or Right [Line Items]                    
Royalty payments description                 (A) royalty payments up to 2% on net sales of licensed products that are not sold by sublicensee and (B) on each and every sublicense earned royalty payment received by licensee from its sublicensee on sales of license product.  
Royalty received by licensee description                 (i) 20% of the royalties received by licensee; or (ii) up to 2% of net sales of sublicensee. The Company will also make milestone payments of up to $4 million and up to $2 million, for the first commercial sale of product in the field that has a single active pharmaceutical ingredient, and for the first commercial sale of product in the field of product that has more than one active pharmaceutical ingredient, respectively.  
Placement Agent [Member]                    
Class of Warrant or Right [Line Items]                    
Advisory services fees     $ 25,000           $ 25,000  
Percent of fully vested warrants to purchase common stock                 5.00%  
Exercise price per share | $ / shares                 $ 7.50  
Issuance of warrants to purchase common stock | shares                 858,190  
Issuance of warrants to purchase common stock description                 The Placement Agent shall also be entitled to the compensation set forth above as well for any cash exercise of Warrants within six (6) months of the final closing of the Offering as well as a five percent (5%) solicitation fee for any Warrants exercised as a result of any redemption of any Warrants. If the Company elects to call the warrants, the Placement Agent shall receive a warrant solicitation fee equal to 5% of the funds solicited by the Placement Agent upon exercise of the warrants.  
Term of warrants                 5 years  
Proceeds from sale of Series A preferred stock               $ 3,089,500 $ 1,830,500 $ 554,700
Proceeds from issuance of subordinated promissory notes                   $ 68,400
Related party transaction, Description of Transaction   In consideration for its services, the placement agent received: (a) re-activation fee of $15,000, (b) a cash fee equal to 7% of the Notes Conversion and 10% of the gross proceeds raised in the Financings, and (c) non-accountable expense reimbursement equal to 2% of the gross proceeds raised. The placement agent or its designees also received warrants to purchase shares of the Company's common stock in an amount equal to 10% of the shares of common stock and warrants issued or issuable as part of the units sold in the Series A Preferred Stock Offering and Notes Offerings.       In consideration for its services, the Placement Agent was eligible to receive: (a) a cash success fee equal to 8% of the value of the transaction plus a 2% non-reimbursable expense fee which was subsequently modified to a maximum of $150,000 plus, (b) $50,000 for a Fairness Opinion fee deductible against the success fee, and (c) a $50,000 activation fee.        
Offering price description         (a) a cash commission in the amount of ten percent (10%) of the gross proceeds of the Offering received from investors at a Closing as well as a non-accountable expense reimbursement equal to two percent; and (b) (2%) of the gross proceeds of the Offering received from investors at a Closing and an activation fee of $25,000.          
Number of agreements | Installments         2          
Activation fee         $ 25,000          
Business acquisition, Description           8% of the aggregate consideration in such transactions, and (ii) if, within a period of 12 months after termination of the services.        
Advisory Firm [Member]                    
Class of Warrant or Right [Line Items]                    
Advisory services fees   $ 12,500             12,500  
Percent of fully vested warrants to purchase common stock   12.00%                
Exercise price per share | $ / shares   $ 0.001                
Maximum reimbursement expenses, monthly                 $ 5,000